Haemonetics (HAE) Total Non-Current Liabilities (2010 - 2026)

Haemonetics' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 1.94% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 1.94% decrease from a year earlier, with the FY2026 full-year figure at $2.3 billion, down 1.94% from the prior year.
• Total Non-Current Liabilities retreated to $2.3 billion in Q1 2026 per HAE's latest filing, from $2.4 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $2.4 billion in Q2 2024 and bottomed at $1.7 billion in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $2.1 billion (2023), against an average of $2.1 billion.
• Across the five-year window, Total Non-Current Liabilities surged 43.53% in 2022 and slipped 2.43% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $1.8 billion in 2022, then climbed by 18.02% to $2.1 billion in 2023, then rose by 14.93% to $2.4 billion in 2024, then slipped by 0.57% to $2.4 billion in 2025, then retreated by 3.74% to $2.3 billion in 2026.
• Per Business Quant, the three latest HAE Total Non-Current Liabilities figures stand at $2.3 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025).